Login
You are not logged in.
Login | Subscribe

RSS feed 

What is RSS?

RSS (Really Simple Syndication) is an XML format of a web site or a weblog designed to allow the distribution and the sharing of information. An RSS feed or web feed provides headlines, brief descriptions and links to the full original content in a standard format.

More information is available on Wikipedia.

What is the benefit of using RSS feeds?

RSS is an easy way for you to be alerted when new content is posted on your chosen web sites, such as the Intellectual Property Watch website. Instead of visiting the IP-Watch website again and again to browse for new stories, the RSS feed automatically tells you when something new is posted.

What do I need to use RSS?

To start using RSS, you need a news reader or aggregator that displays RSS feeds from web sites or weblogs you selected. There are many different news readers, available as applications to be installed on your computer or as web services. Some web browsers such as Firefox and Safari can display RSS feeds too.

You can find a list on RSS Compendium.

Once you have set up your news reader, you simply subscribe to the RSS feeds you want.

How do I subscribe to the IP-Watch RSS feed?

Copy the URL of the IP-Watch RSS feed as provided in the left margin to your clipboard. Then follow the instructions on your particular news reader for adding / subscribing to RSS feeds.

Email alerts 

You can subscribe for free to receive automatic email notifications whenever new content is available on the Intellectual Property Watch website. Moreover, you can configure the alerts to fit your needs and interests by defining the frequency, the type of content and even the language.

Subscribe/free trial 

Intellectual Property Watch subscribers receive exclusive access to stories published on the website under password protection, plus the Intellectual Property Watch monthly edition, a 16-page selection of the most important stories and features, including the People column and News Briefs section not available anywhere else. These columns contain the latest on personnel changes in the international IP community, and items on IP policy news and reports from around the world. The Intellectual Property Watch Monthly Reporter is available online and in print, mailed to your door.


Global IP Policy in 2010:
What You Need To Know
IP-Watch Year Ahead Series

Advertise Here

Latest Comments
Inside Views

Contribute your views! Submit an Inside Views idea on any relevant topic to info [at] ip-watch [dot] ch, or leave a comment within any piece such as below.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

The US-Cotton Case: The Truth Behind Brazil’s Cross-Retaliation Against US Intellectual Property

In a recent speech at the Export-Import Bank’s annual conference, US President Obama said the US Trade Representative will use its “full arsenal” to combat “practices that blatantly harm” US businesses, and that includes “enforcing existing [US] agreements.” The question is: will the US comply with its multilateral obligations under the WTO agreement in the US-Brazil cotton case, says Brazilian academic Pedro Paranaguá.


Interview With Bill Pollock, Founder Of No Starch Press

Bill Pollock is the president and founder of No Starch Press, which publishes books on computing. Known to offer the “finest in geek entertainment,” the publishing house has released such titles as “Steal This Computer Book,” “How Linux Works,” “Hacking: The Art of Exploitation,” “The Cult of Mac,” and “The Unofficial LEGO Builder’s Guide.” Its books are largely about hacking, open source, security, programming, and non-Windows-based operating systems, such as Linux. Mr. Pollock shared his thoughts with Intellectual Property Watch about hacking, piracy, and future of the book publishing business.


Intellectual Property Watch
15 October 2009

专家组:获取安全药品是公共卫生问题而非知识产权问题

By Catherine Saez @ 9:39 am

在最近由开放社会协会(Open Society Institute)主办的一次会议上,与会专家表示,反假冒倡议可能阻碍人们获得药品,但无法解决假药问题,在发展中国家尤其如此。

专家们说,把合法仿制药、劣质药品与盗版商标产品商标的药品混为一谈可能会带来灾难性的后果,对假冒药品的精确定义和界定范围势在必行。

根据医生无国界(Médecins Sans Frontières)组织的一份文件,假冒药品是指有意包装使之看起来合法而实际并非如此的药品。这属于商标侵权。另一方面,次级药品是指合法生产但不符合相关药品管理部门规定标准的药品。这属于质量控制问题。最后,仿制药是指合法生产的与原一般无专利保护药品相同且含有相同有效成分的药品。

第三世界工作网(Third World Network)高级法律顾问散吉塔•沙石康(Sangeeta Shashikant)在9月25日的会议上发言,“当我们谈到反假冒倡议时,基本上是指全球知识产权保护执行议程。”

沙石康说,在国家层面上,发展中国家特别是非洲国家,正在推动知识产权保护措施的实施。例如,肯尼亚通过了一项反假冒法案,乌干达也在讨论这个。

沙石康表示,这个问题属于该类法律的范围。在世界贸易组织《与贸易有关的知识产权协议》(TRIPS)里,假冒定义为与商标侵权有关。肯尼亚法案超越了《与贸易有关的知识产权协议》,假冒覆盖了所有的知识产权侵权,比如专利、商标、版权、工业设计,甚至包括植物品种保护。

她说,药品质量应由药品监管部门而非海关负责,因为海关官员不具备鉴别一个商品是否侵犯知识产权的能力。她主张知识产权的侵权问题应由知识产权官员鉴定。

印度常驻日内瓦联合国代表团参赞帕纱•萨帕西(Partha Satpathy)表示赞同,海关官员不具备鉴别药品质量的能力。沙石康指出,知识产权所有者的一丁点儿怀疑就能导致商品在边境滞留扣押数月。过去几年这样的事在欧洲不止一次上演,主要发生在荷兰。

巴西常驻日内瓦联合国代表团参赞艾里奥•卡杜叟(Elio Cardoso)指出,在次级药品和仿制药之间肯定没有任何概念混淆,但有时也会人为故意混淆。

所有与会者都同意获取安全药品不应列入知识产权框架,而应进入公共卫生框架。卡杜叟表示,“在世界卫生组织,对药品的获取应集中于公共卫生问题而非知识产权上。”

对于医生无国界组织的米歇尔•查尔兹(Michelle Childs)来说,获取药品问题不仅指获得现有的治疗手段,也包括获得新治疗手段。她说,印度法律现在有了新的知识产权规定,一些新型抗艾滋病毒药品受专利保护,阻碍了人们获得新药。

 


Leave a Reply

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.